Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages
MR Walker, A Underwood, KH Björnsson… - Communications …, 2024 - nature.com
The continuous emergence of SARS-CoV-2 variants of concern has rendered many
therapeutic monoclonal antibodies (mAbs) ineffective. To date, there are no clinically …
therapeutic monoclonal antibodies (mAbs) ineffective. To date, there are no clinically …
Novel, broad and potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages
The continuous emergence of SARS-CoV-2 variants of concern with mutated spike receptor
binding domains has rendered many therapeutic mAbs ineffective. To date, there are no …
binding domains has rendered many therapeutic mAbs ineffective. To date, there are no …